Browsing Tag
Morningside Group
2 posts
Sleep apnoea biotech Apnimed (APMD) climbs in Nasdaq debut after upsized offering
Apnimed raised $192M in an upsized Nasdaq IPO to fund oxnimbi's launch, with the FDA's February 28, 2027 decision on the first oral OSA pill now the pivot.
AstraZeneca and Imperial spin-off VaxEquity enter into saRNA partnership
AstraZeneca has signed a collaboration deal with VaxEquity, a spin-off of Imperial College London, for discovering, developing, and…